Correlation Between Equillium and Qualigen Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Equillium and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Qualigen Therapeutics, you can compare the effects of market volatilities on Equillium and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Qualigen Therapeutics.

Diversification Opportunities for Equillium and Qualigen Therapeutics

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Equillium and Qualigen is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Equillium i.e., Equillium and Qualigen Therapeutics go up and down completely randomly.

Pair Corralation between Equillium and Qualigen Therapeutics

Allowing for the 90-day total investment horizon Equillium is expected to generate 0.89 times more return on investment than Qualigen Therapeutics. However, Equillium is 1.13 times less risky than Qualigen Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  89.00  in Equillium on September 13, 2024 and sell it today you would lose (19.00) from holding Equillium or give up 21.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Equillium  vs.  Qualigen Therapeutics

 Performance 
       Timeline  
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Equillium and Qualigen Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Equillium and Qualigen Therapeutics

The main advantage of trading using opposite Equillium and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.
The idea behind Equillium and Qualigen Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing